Conference · Boston, Massachusetts
CDD for Biologics Summit Boston
Health · Biology
Key numbers
- Editions on record
- 1first in 2017
About CDD for Biologics Summit Boston
Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture. The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics. Designed with input from thought leaders at organizations such as Genentech, Bristol-Myers Squibb, AbbVie, EMD Serono and Novartis, identify how to streamline your early drug discovery pipeline, enhance developability and improve the success rate of lead biologic candidates. * Please note: We also offer a start-up rate for small biotech organisations, as well as academic discounts. For more information and to check eligibility criteria, please visit the website. *
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 5–7 Dec 2017 | Revere Hotel – Boston Common Boston, Massachusetts | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is CDD for Biologics Summit Boston?
The next dates haven't been confirmed. The last edition we have on record was 5–7 Dec 2017.
Where is it held?
The last edition we have was at Revere Hotel – Boston Common, Boston, Massachusetts.